HPV-specific antibodies at the oral cavity up to 30 months after the start of vaccination with the quadrivalent HPV vaccine among mid-adult aged men
- 17 April 2019
- Vol. 37 (21), 2864-2869
- https://doi.org/10.1016/j.vaccine.2019.03.064
Abstract
No abstract availableKeywords
Funding Information
- Investigator-Initiated Studies Program of Merck Sharp & Dohme Corp
- Moffitt Cancer Center in Tampa, Florida
- National Cancer Institute
- National Institutes of Health (HHSN261200800001E)
This publication has 23 references indexed in Scilit:
- Reduced Prevalence of Oral Human Papillomavirus (HPV) 4 Years after Bivalent HPV Vaccination in a Randomized Clinical Trial in Costa RicaPLOS ONE, 2013
- Annual Report to the Nation on the Status of Cancer, 1975–2009, Featuring the Burden and Trends in Human Papillomavirus (HPV)–Associated Cancers and HPV Vaccination Coverage LevelsJNCI Journal of the National Cancer Institute, 2013
- Secretory immunity with special reference to the oral cavityJournal of Oral Microbiology, 2013
- Development and application of a GuHCl-modified ELISA to measure the avidity of anti-HPV L1 VLP antibodies in vaccinated individualsMolecular and Cellular Probes, 2012
- Oral Immunoglobulin Levels are Not a Good Surrogate for Cervical Immunoglobulin LevelsFrontiers in Oncology, 2012
- New Approaches to Immunotherapy for HPV Associated CancersCancers, 2011
- Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in MalesNew England Journal of Medicine, 2011
- Characterization of the HPV-specific memory B cell and systemic antibody responses in women receiving an unadjuvanted HPV16 L1 VLP vaccineVaccine, 2010
- Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young womenThe Lancet, 2009
- High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-upBritish Journal of Cancer, 2006